🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  2. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials

  3. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  4. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  5. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  6. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  7. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  8. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial

  9. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  10. pregabalin

    Pfizer

    Diabetic Neuropathy, Painful

    approved small molecule completed

    1 trial

  11. pregabalin and celecoxib

    Pfizer

    Chronic Low Back Pain With a Neuropathic Component

    approved small molecule terminated

    1 trial

  12. premeal insulin lispro mixtures

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  13. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  14. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  15. quetiapine fumarate tablet (Seroquel)

    The First People's Hospital of Lianyungang

    Bipolar Disorder

    approved small molecule active

    1 trial

  16. rFVIIIFc

    Sanofi Pasteur

    Hemophilia A With Inhibitors

    approved mab completed

    1 trial

  17. recombinant human erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Birth

    approved small molecule completed

    1 trial

  18. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    1 trial

  19. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  20. recombinant human thrombopoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombocytopenia

    approved small molecule completed

    1 trial

  21. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

  22. rhTPO

    The First People's Hospital of Lianyungang

    Thrombocytopenia

    approved small molecule active

    1 trial

  23. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Previously Treated Primary Immune Thrombocytopenia

    approved small molecule completed

    1 trial

  24. rhTPO

    The First People's Hospital of Lianyungang

    Primary Immune Thrombocytopenia

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources